SVRA Stock Analysis: Buy, Sell, or Hold?

SVRA - Savara Inc.

PHARMACEUTICAL PREPARATIONS
$5.69
-0.06 (-0.96%) ▼
5d: -8.45%
30d: +7.87%
90d: -3.97%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 12, 2026 28d

Get Alerted When SVRA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: SVRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: SVRA is currently trading at $5.68, which is considered fair relative to its 30-day fair value range of $5.25 to $6.14.

Technical Outlook: Technically, SVRA is in a strong uptrend. The price is currently testing key support at $5.66. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.94 (+90.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $5.25 - $6.14
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 74.7%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 90.5% below Wall St target ($10.94)
  • CAUTION: Recommendation downgraded due to -8.5% 5-day decline

Trading Range Analysis

30-Day Trading Range $5.25 - $6.14
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $5.66
Resistance Level $6.48
Current Trend Strong Uptrend
Technical data as of Jul 13, 2026

Fundamental Context

Forward P/E (Next Year Est.) -19.52
Wall Street Target $10.94 (+90.5%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 14, 2026 10:42 AM ET
Data refreshes hourly during market hours. Next update: 11:42 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SVRA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$441 60 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 62 BUY
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$102 67 BUY
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$258 67 BUY
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$32 61 BUY

More Analysis for SVRA

SVRA Technical Chart SVRA Price Prediction SVRA Earnings Date SVRA Investment Advisor SVRA Fair Price Analyzer SVRA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals